ClinicalTrials.gg
Active, not recruitingNCT03377205Updated Jul 13, 2023

Intramedullary Nailing Versus Plate Fixation of Ankle Fractures. A Prospective, Randomized Controlled Trial.

An interventional study of Compression screws and neutralization plate and Acumed Fibular Rod System in Ankle Fractures, sponsored by Oslo University Hospital. Active, not recruiting at 1 site in Norway. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2023-07-13.

Sponsored by Oslo University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Jun 2016, registered Mar 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 12 studies in Ankle Fractures with a site in Norway — 2 open to participants now, 6 under way, none of them phase 3. Ankle Fractures · Norway.

Enrollment
3rd of 11
120 · median 120
Started
2016
with 1 other
No phase
10 of 12
2 open now
Registered
4th of 12
by date
Lead sponsor
4 of 12
Oslo University Hospital

Among the 12 studies in Ankle Fractures with a site in Norway, this one is the 3rd largest by enrollment of the 11 interventional ones that give a count, is one of 2 that started in 2016, is one of 10 with no phase, and was the 4th registered.

Ankle Fractures

202 studies on the registry are indexed under Ankle Fractures; 44 are open to participants now.

Browse Ankle Fractures studies →

Open to participants now

2 of the 12 studies in Ankle Fractures with a site in Norway are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Norway have not opened yet or have stopped. Only those recruiting at a site in Norway →

Who these studies take

Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Ankle Fractures with a site in Norway, or all of them as a file.
02

Study summary

The purpose of this study is to make a survey of functional outcome, radiological outcome and complication rate after intramedullary nailing (IMN) and plate fixation of Weber B ankle fractures in elderly patients, and contribute in choosing the best surgical method for these ankle fractures.

Read the detailed description

Open reduction and internal fixation (ORIF) is the gold standard treatment for unstable Weber B fractures, using compression screws and a neutralization plate. In the elderly, pre-existing co-morbidities, osteoporosis and poor skin conditions may give a high complication rate, including wound complications, symptomatic hardware and hardware failure. Due to concerns with complications related to ORIF, the technique with intramedullary fixation has been introduced. This method may simplify the management when poor skin conditions and osteoporotic bone, and has the potential to reduce the risk of soft tissue and hardware complications. Previous studies have showed that intramedullary fixation is probably the best choice for treating unstable ankle fractures in elderly patients, but more studies are needed to conclude the superiority to standard plate fixation.

03

Conditions studied

  • Ankle Fractures

Browse trials for

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Acute unstable Weber B fracture (unimalleolar, bimalleolar or trimalleolar fractures).
  • Operable with both methods of surgery within 3 weeks after injury.
  • Men and women ≥ 60 yoa.

Exclusion criteria

Exclusion Criteria:

  • Prior injury or pathology with reduced ankle function.
  • Other acute foot/ankle/leg injury that will affect ankle function.
  • Fracture of the posterior malleolus that need fixation.
  • Injury / pathology that may affect rehabilitation.
  • Open fracture.
  • Inoperable patient.
  • Dementia ( score ≤ 24 points), reduced competent to consent, not able to express himself/herself in Norwegian or English.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
120 participants (actual)

Study arms

  • Active comparator
    Plate

    Compression screws and neutralization plate.

    Device: Compression screws and neutralization plate

  • Experimental
    Intramedullary nail

    Acumed Fibular Rod System

    Device: Acumed Fibular Rod System

Interventions

  • DeviceCompression screws and neutralization plate

    Open reduction and internal fixation with screws and plate

  • DeviceAcumed Fibular Rod System

    intramedullary nailing of fibula

06

What researchers measure

Primary outcomes

  1. American Orthopaedic Foot and Ankle Society (AOFAS) score

    Functional outcome as assessed by AOFAS score (0-100)

    Time frame: 5 years

Secondary outcomes

  1. Manchester-Oxford Foot questionnaire (MOxFQ)

    Patient reported outcome as assessed by MOxFQ (0-100)

    Time frame: 5 years

  2. Olerud and Molander Score (OMS)

    Patient reported outcome as assessed by OMS (0-100)

    Time frame: 5 years

  3. EuroQol-5d (Eq-5d)

    Patient reported quality of life as assessed by Eq-5d index score

    Time frame: 5 years

  4. Visual analogue scale (VAS)

    VAS scores for pain during rest (0-10), during walking (0-10), at night (0-10), and during daily activities (0-10), where 10 is best

    Time frame: 5 years

  5. Fracture reduction as assessed by CT scans

    Number of patients with good, fair or poor fracture reduction

    Time frame: 3 months

  6. Malunion as assessed by CT scans

    Number of patients with malunion

    Time frame: 5 years

  7. Nonunion as assessed by CT scans

    Number of patients with nonunion

    Time frame: 5 years

  8. Osteoarthritis as assessed by CT scans

    Number of patients with osteoarthritis assessed according to the criteria by McLennan et al

    Time frame: 5 years

  9. Infection

    Number of patients with wound infection or deep infection

    Time frame: 3 months

  10. Delayed wound healing

    Number of patients with delayed wound healing

    Time frame: 3 months

  11. Other complications

    Number of patients with other complications (e.g. hardware complications, tromboemolism, neurologic complications, peroneus tendon irritation)

    Time frame: 5 years

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jun 2016 to primary completion in Jun 2021, 60 months.

Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's 60 months is above that.

Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 21, 2017
First posted
Dec 19, 2017
StartActual
Jun 2016
Primary completionActual
Jun 2021
CompletionEst.
Jan 2026
Last update
Jul 13, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 13, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03377205
Collaborators
Ostfold Hospital Trust, Vestre Viken Hospital Trust
Responsible party
Elisabeth Ellingsen Husebye (Principal investigator, Oslo University Hospital) — Principal investigator
First posted
Dec 19, 2017
Start date
Jun 2016
Primary completion
Jun 2021
Completion
Jan 2026 (estimated)
Last update
Jul 13, 2023

Study contacts

Elisabeth E Husebye, MD, PhD
study chair · Oslo University Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Jul 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion